Rationally Evolving MCP-1/CCL2 into a Decoy Protein with Potent Anti-inflammatory Activity in Vivo
Open Access
- 1 March 2010
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 285 (12), 8782-8792
- https://doi.org/10.1074/jbc.m109.043299
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivoJournal of Leukocyte Biology, 2008
- Positive correlation between pigment epithelium-derived factor and monocyte chemoattractant protein-1 levels in the aqueous humour of patients with uveitisBritish Journal of Ophthalmology, 2006
- Anti–MCP-1 Gene Therapy Inhibits Vascular Smooth Muscle Cells Proliferation and Attenuates Vein Graft Thickening Both In Vitro and In VivoArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Monocyte chemoattractant protein (MCP‐1) is expressed in human cardiac cells and is differentially regulated by inflammatory mediators and hypoxiaFEBS Letters, 2006
- Developing chemokine mutants with improved proteoglycan affinity and knocked-out GPCR activity as anti-inflammatory recombinant drugsBiochemical Society Transactions, 2006
- Heparan sulfate and inflammationNature Immunology, 2005
- Targeting CCR2 or CD18 Inhibits Experimental In-Stent Restenosis in PrimatesCirculation Research, 2002
- Molecular Cloning and Functional Expression of Murine JE (Monocyte Chemoattractant Protein 1) and Murine Macrophage Inflammatory Protein 1α ReceptorsPublished by Elsevier BV ,1996
- Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1β production by synovial T cellsClinical and Experimental Immunology, 1995
- Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis.JCI Insight, 1992